Cargando…
Osteoclast Differentiation Is Impaired in a Subgroup of SLE Patients and Correlates Inversely with Mycophenolate Mofetil Treatment
Osteoporosis can arise in systemic lupus erythematosus (SLE) patients secondary to medication and/or chronic inflammation. To analyze if patients with SLE have phenotypically-impaired osteoclastogenesis, we differentiated ex vivo monocytes from 72 SLE patients and 15 healthy individuals into osteocl...
Autores principales: | Fürnrohr, Barbara G., Rhodes, Benjamin, Munoz, Luis E., Weiß, Katrin, Vyse, Tim J., Schett, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581274/ https://www.ncbi.nlm.nih.gov/pubmed/26274951 http://dx.doi.org/10.3390/ijms160818825 |
Ejemplares similares
-
The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes
por: Rhodes, Benjamin, et al.
Publicado: (2012) -
Mycophenolate mofetil prevents the development of a clinical relapse in SLE patients at risk: an open pilot study
por: Bijl, M, et al.
Publicado: (2002) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022) -
Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008) -
Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)